Literature DB >> 3536525

A comparison of intracavitary talc and tetracycline for the control of pleural effusions secondary to breast cancer.

I S Fentiman, R D Rubens, J L Hayward.   

Abstract

Forty-one patients with malignant pleural effusions secondary to breast cancer were randomly allocated to treatment with either intracavitary talc or intracavitary tetracycline. Of 33 evaluable patients, radiological control was achieved in 11/12 (92%) of the talc group compared with 10/21 (48%) of the tetracycline group (P = 0.022). Intracavitary talc provides effective palliation of metastatic pleural effusions secondary to breast cancer.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3536525     DOI: 10.1016/0277-5379(86)90009-x

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  15 in total

1.  BTS guidelines for the management of malignant pleural effusions.

Authors:  G Antunes; E Neville; J Duffy; N Ali
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

2.  Palliative iodized talc pleurodesis with instillation via tube thoracostomy.

Authors:  A Türler; M Gawenda; M Walter
Journal:  Support Care Cancer       Date:  1997-01       Impact factor: 3.603

Review 3.  Management of malignant pleural effusions.

Authors:  F Grossi; M C Pennucci; L Tixi; M A Cafferata; A Ardizzoni
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

Review 4.  The role of thoracoscopy in the evaluation and management of pleural effusions.

Authors:  C Boutin; P Astoul; B Seitz
Journal:  Lung       Date:  1990       Impact factor: 2.584

5.  Talc pleurodesis in malignant pleural effusion: a systematic review and meta-analysis.

Authors:  Eleftherios T Beltsios; Georgios Mavrovounis; Antonis Adamou; Nikolaos Panagiotopoulos
Journal:  Gen Thorac Cardiovasc Surg       Date:  2020-11-22

6.  Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion.

Authors:  Carolyn M Dresler; Jemi Olak; James E Herndon; William G Richards; Ernest Scalzetti; Stewart B Fleishman; Kemp H Kernstine; Todd Demmy; David M Jablons; Leslie Kohman; Thomas M Daniel; George B Haasler; David J Sugarbaker
Journal:  Chest       Date:  2005-03       Impact factor: 9.410

7.  Management of recurrent malignant pleural effusion in the United Kingdom: survey of clinical practice.

Authors:  L G McAlpine; G Hulks; N C Thomson
Journal:  Thorax       Date:  1990-09       Impact factor: 9.139

Review 8.  Malignant pleural effusions: appropriate treatment approaches.

Authors:  Yener Aydin; Atila Turkyilmaz; Yavuz Selim Intepe; Atilla Eroglu
Journal:  Eurasian J Med       Date:  2009-12

Review 9.  Diagnosis and management of malignant pleural effusions: state of the art in 2017.

Authors:  Neeraj R Desai; Hans J Lee
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

10.  Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions.

Authors:  A G Villanueva; A W Gray; D M Shahian; W A Williamson; J F Beamis
Journal:  Thorax       Date:  1994-01       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.